• 1
    Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552568.
  • 2
    Poser CM, Paty DW, Scheinberg LC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227231.
  • 3
    Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000; 47: 831835.
  • 4
    Gronseth GS, Ashman EJ. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 17201725.
  • 5
    Uthoff W. Untersuchungen über bei multiplen Herdsklerose vorkommenden Augenstorungen. Arch Psychiatr Nervenkrankh 1890; 21: 55106, 303–410.
  • 6
    Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 20592069.
  • 7
    Tintoré M, Rovira A, Martínez M, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 2000; 21: 702706.
  • 8
    Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988; 38: 18221825.
  • 9
    Offenbacher H, Fazekas F, Schmidt R, et al. Assessment of MRI criteria for a diagnosis of MS. Neurology 1993; 43: 905909.
  • 10
    Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology 1988; 38: 180185.
  • 11
    Thorpe JW, Kidd D, Kendall BE, et al. Spinal cord MRI using multi-array coils and fast spin echo. I. Technical aspects and findings in healthy adults. Neurology 1993; 43: 26252631.
  • 12
    Kidd C, Thorpe JW, Thompson AJ, et al. Spinal cord imaging MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 26322637.
  • 13
    Brex PA, O'Riordan JI, Miszkiel KA, et al. Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology 1999; 53: 11841190.
  • 14
    Andersson M, Alvarez-Cermeno J, Bernardi G, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatr 1994; 57: 897902.
  • 15
    Link H, Tibbling G. Principles of albumin and IgG analysis in neurological disorders. III. valuation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977; 37: 397401.
  • 16
    HallidayAM, editor. Evoked potentials in clinical testing, 2nd ed. London: Churchill Livingstone, 1993.
  • 17
    Dale RC, DeSousa C, Chong WK, et al. Acute disseminated encephalomyelitis and multiple sclerosis in children. A follow-up study to compare clinical and investigative findings on disease presentation. Brain 2000; 123: 24072422.
  • 18
    Gallagher HL, MacManus DG, Webb SL, Miller DH. A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis. J Magnet Reson Imag 1997; 7: 439441.
  • 19
    Matthews B. Differential diagnosis of multiple sclerosis and related disorders. In: CompstonA, EbersG, LassmannH, et al, editors. McAlpine's multiple sclerosis, 3rd ed. London: Churchill Livingstone, 1998.
  • 20
    Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 11071114.
  • 21
    Phadke JG, Best PV. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. J Neurol Neurosurg Psychiatr 1983; 46: 414420.
  • 22
    Brex FA, Miszkiel KA, O'Riordan JI, et al. Assessing the risk of early MS in patients with clinically isolated syndromes: the role of follow-up MRI. J Neurol Neurosurg Psychiatr 2001; 70: 390393.